About this episode

The episode discusses the current impact of AI in the pharmaceutical industry and the importance of immediate adoption.

Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Emily Lewis, Artificial Intelligence and Innovation Lead for Digital Care Transformation at UCB, to explore why LLMs alone won’t move medicine forward, how to build cross-functional AI literacy ...

People in this episode

Host: Jonathan Kaskey

Guest: Emily Lewis

Topics covered

• AI in healthcare
• pharmaceutical industry
• cross-functional AI literacy
• regulatory workflows
• digital care transformation

Keywords

• AI
• pharma
• healthcare
• ChatGPT
• digital transformation
• regulatory impact
• cross-functional literacy

Mentioned in this episode

Organizations: UCB

Products: ChatGPT

More episodes of Pharma Sessions

• How Medical Affairs Becomes the Connector with Sonia Talwar · April 23, 2026 · 26 min
• Why Manufacturing Is the New Competitive Edge in Cell and Gene Therapy · April 16, 2026 · 33 min
• The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2 · April 9, 2026 · 21 min
• The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 1 · April 2, 2026 · 32 min
• How AI Is Reshaping Pharma’s Commercial Operations with Punit Kumar · March 26, 2026 · 38 min
• Why Pharma products win or lose years before launch · March 19, 2026 · 31 min

Explore listener stats, chart rankings, contacts and more on the Pharma Sessions podcast page.